A successful spectacle lens fitting for myopia

In this case, a colleague has his first experience with the new Essilor Stellest spectacle lens for childhood myopia, with discussion including when to change the prescription and when to stop treatment.

Understanding the new Essilor Stellest spectacle lens

Spectacle lenses which effectively control myopia progression are the next phase in widespread uptake of myopia management. Learn more about the Essilor Stellest lens, from myopia control to vision and visual function outcomes.

The importance of myopia control soft contact lens design

Increasing power in a myopia control treatment zone of a multifocal soft contact lens can increase myopia control efficacy but negatively impact vision. This study is the first optical characterization of a novel design to improve this relationship between treatment zone power and vision quality.

Two-year clinical trial results of aspherical lenslet spectacles for myopia control

This study reports two year results from a randomized clinical trial examining myopia control spectacle lenses with highly aspherical lenslets (HAL) or slightly aspherical lenslets (SAL). The findings showed the HAL lens controlled refractive and axial progression by 50-55% and SAL by around 30% over two years. Read more about the outcomes and comparisons to other myopia control spectacles here.

A monocular myope with coloboma

An 8-year-old child is essentially monocular, due to unilateral high myopia associated with coloboma. The normally sighted eye has low myopia. How should we best balance safety and proactive myopia control in such a case?

The next generation – DIMS and H.A.L.T. technology spectacle lenses for myopia control

The newest myopia controlling spectacles can both correct and control myopia as effectively as contact lens options. How do Defocus Incorporated Multiple Segments (DIMS) and HIghly Aspherical Lenslet Target (H.A.L.T.) technology spectacle lenses work? Here we investigate and compare their design, presumed mechanism and comparative efficacy for myopia control, based on published research.

One-year myopia control efficacy of spectacle lenses with aspherical lenslets

This study reports one year results from an ongoing randomized clinical trial examining spectacle lenses with highly aspherical lenslet (HAL) or slightly aspherical lenslet (SAL) technology. The findings showed the HAL lens controlled refractive and axial progression by 60-70% and SAL by 30-40% over the first 12 months.